Aerpio Pharmaceuticals Inc (ARPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARPO | BMY | AMGN | GILD | MRNA |
| Company | Aerpio Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 33.30 | 49.00 | 270.63 | 66.58 | 111.05 |
| High | 34.50 | 49.00 | 274.47 | 67.19 | 111.29 |
| Low | 32.40 | 48.55 | 269.65 | 66.37 | 106.64 |
| Last | 33.00 | 48.78 | 274.02 | 66.99 | 107.81 |
| Change | -0.30 | -0.21 | +0.48 | -0.04 | -0.08 |
| % Change | -0.90% | -0.43% | +0.18% | -0.06% | -0.07% |
| Volume | 55,066 | 4,949,752 | 739,545 | 2,753,983 | 2,136,868 |
| 20-Day Average Volume | 2,010,460 | 10,696,474 | 2,084,875 | 6,202,145 | 3,160,239 |
| Previous Close | 33.30 | 48.99 | 273.54 | 67.03 | 107.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.12 | 50.36 | 271.60 | 69.07 | 105.13 |
| 20-Day Raw Stochastic | 31.91% | 16.55% | 47.62% | 13.36% | 52.89% |
| 20-Day Relative Strength | 54.13% | 40.69% | 49.12% | 32.63% | 54.33% |
| Weighted Alpha | +30.52 | -26.25 | +11.69 | -20.96 | -10.51 |
| Today's Opinion | 100% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.56% since 08/19/21 | +1.90% since 04/17/24 | +3.75% since 04/17/24 | +0.05% since 04/17/24 | +3.43% since 04/17/24 |
| Low | 2.07 on 08/20/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 99.30 on 04/22/24 |
| High | 2.30 on 08/26/21 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 111.19 on 04/24/24 |
| 1-Month | |||||
| %Chg | +3.77% since 07/26/21 | -6.12% since 03/22/24 | -0.80% since 03/22/24 | -7.77% since 03/22/24 | +1.48% since 03/22/24 |
| Low | 1.98 on 08/04/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 2.68 on 08/17/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +30.18% since 05/26/21 | -2.97% since 01/24/24 | -10.32% since 01/24/24 | -15.80% since 01/24/24 | +5.82% since 01/24/24 |
| Low | 1.62 on 06/29/21 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 3.32 on 07/08/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +23.60% since 02/26/21 | -13.13% since 10/24/23 | -0.78% since 10/24/23 | -14.31% since 10/24/23 | +34.14% since 10/24/23 |
| Low | 0.95 on 05/10/21 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 3.32 on 07/08/21 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,852 | 99,290,928 | 146,720,288 | 83,457,512 | 41,308,924 |
| Shares Outstanding, K | 47,660 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 15,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -4,320,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -4,410,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 1.69 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 08/11/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 0.00 |